Nayak L - Search Results

1

PCV for anaplastic oligodendrogliomas: back to the future or a step backwards? A point/counterpoint discussion.

Villano JL, Wen PY, Lee EQ, Nayak L, Reardon DA, Rosenfeld MR. Villano JL, et al. Among authors: nayak l. J Neurooncol. 2013 May;113(1):143-7. doi: 10.1007/s11060-013-1100-z. Epub 2013 Mar 12. J Neurooncol. 2013. PMID: 23479035 No abstract available.

2

Epidemiology of brain metastases.

Nayak L, Lee EQ, Wen PY. Nayak L, et al. Curr Oncol Rep. 2012 Feb;14(1):48-54. doi: 10.1007/s11912-011-0203-y. Curr Oncol Rep. 2012. PMID: 22012633

3

Atypical and anaplastic meningiomas treated with bevacizumab.

Nayak L, Iwamoto FM, Rudnick JD, Norden AD, Lee EQ, Drappatz J, Omuro A, Kaley TJ. Nayak L, et al. J Neurooncol. 2012 Aug;109(1):187-93. doi: 10.1007/s11060-012-0886-4. Epub 2012 Apr 29. J Neurooncol. 2012. PMID: 22544653

4

Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.

Nayak L, Abrey LE, Drappatz J, Gilbert MR, Reardon DA, Wen PY, Prados M, Deangelis LM, Omuro A; North American Brain Tumor Consortium. Nayak L, et al. Leuk Lymphoma. 2013 Jan;54(1):58-61. doi: 10.3109/10428194.2012.698736. Epub 2012 Jul 9. Leuk Lymphoma. 2013. PMID: 22656234 Free PMC article. Clinical Trial.

5

Treatment options in newly diagnosed glioblastoma.

Lee EQ, Nayak L, Wen PY, Reardon DA. Lee EQ, et al. Among authors: nayak l. Curr Treat Options Neurol. 2013 Jun;15(3):281-8. doi: 10.1007/s11940-013-0226-9. Curr Treat Options Neurol. 2013. PMID: 23553038

6

Update on bevacizumab and other angiogenesis inhibitors for brain cancer.

Rinne ML, Lee EQ, Nayak L, Norden AD, Beroukhim R, Wen PY, Reardon DA. Rinne ML, et al. Among authors: nayak l. Expert Opin Emerg Drugs. 2013 Jun;18(2):137-53. doi: 10.1517/14728214.2013.794784. Epub 2013 May 14. Expert Opin Emerg Drugs. 2013. PMID: 23668489 Review.

7

Retrospective study of pemetrexed as salvage therapy for central nervous system lymphoma.

Zhang JP, Lee EQ, Nayak L, Doherty L, Kesari S, Muzikansky A, Norden AD, Chen H, Wen PY, Drappatz J. Zhang JP, et al. Among authors: nayak l. J Neurooncol. 2013 Oct;115(1):71-7. doi: 10.1007/s11060-013-1196-1. Epub 2013 Jul 5. J Neurooncol. 2013. PMID: 23828279

8

The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

Olson JJ, Nayak L, Ormond DR, Wen PY, Kalkanis SN; AANS/CNS Joint Guidelines Committee. Olson JJ, et al. Among authors: nayak l. J Neurooncol. 2014 Jul;118(3):501-55. doi: 10.1007/s11060-013-1338-5. Epub 2014 Apr 17. J Neurooncol. 2014. PMID: 24740194 Review.

9

The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

Olson JJ, Nayak L, Ormond DR, Wen PY, Kalkanis SN, Ryken TC; AANS/CNS Joint Guidelines Committee. Olson JJ, et al. Among authors: nayak l. J Neurooncol. 2014 Jul;118(3):557-99. doi: 10.1007/s11060-013-1339-4. Epub 2014 Apr 17. J Neurooncol. 2014. PMID: 24740195 Review.

10

Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.

Aizer AA, Arvold ND, Catalano P, Claus EB, Golby AJ, Johnson MD, Al-Mefty O, Wen PY, Reardon DA, Lee EQ, Nayak L, Rinne ML, Beroukhim R, Weiss SE, Ramkissoon SH, Abedalthagafi M, Santagata S, Dunn IF, Alexander BM. Aizer AA, et al. Among authors: nayak l. Neuro Oncol. 2014 Nov;16(11):1547-53. doi: 10.1093/neuonc/nou098. Epub 2014 Jun 2. Neuro Oncol. 2014. PMID: 24891451 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

295 results

Search Page